(Q30893394)

15 October 2017

Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data (English)

1 reference

15 October 2017

1 reference

1 reference

Monica A Konerman

1

1 reference

15 October 2017

Yiwei Zhang

2

1 reference

15 October 2017

Ji Zhu

3

1 reference

15 October 2017

Peter D R Higgins

4

1 reference

15 October 2017

Anna S F Lok

5

1 reference

15 October 2017

Akbar K Waljee

6

1 reference

15 October 2017

language of work or name

English

0 references

publication date

20 March 2015

1 reference

15 October 2017

1 reference

15 October 2017

61

1 reference

15 October 2017

6

1 reference

15 October 2017

1832-1841

1 reference

Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring--predictors and predictive models of disease progression

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Comparison of imputation methods for missing laboratory data in medicine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Sofosbuvir for previously untreated chronic hepatitis C infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Does antiviral therapy prevent hepatocellular carcinoma?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Role of simple biomarkers in predicting fibrosis progression in HCV infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Evolving epidemiology of hepatitis C virus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Algorithms outperform metabolite tests in predicting response of patients with inflammatory bowel disease to thiopurines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480773

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

21 June 2018

1 reference

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests

21 January 2018

1 reference

Progression of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy

21 January 2018

1 reference

Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C infection

21 January 2018

1 reference

Machine learning in medicine: a primer for physicians.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.27750

1 reference

15 October 2017

1 reference

15 October 2017

1 reference